In Pain relief Dacron Plus Tablet belongs to a group of medicines called nonsteroidal anti-inflammatory drugs (NSAIDs). It is used for short-term relief of pain, inflammation, and swelling in conditions that affect joints and muscles. It works by blocking chemical messengers in the brain that tell us we have pain. It can help relieve pain in conditions like rheumatoid arthritis and osteoarthritis. Take it as it is prescribed to get the most benefit. Do not take more or longer than needed as that can be dangerous. In general, you should take the lowest dose that works, for the shortest possible time. This will help you to go about your daily activities more easily and have a better, more active, quality of life.
It is not known whether it is safe to consume alcohol with Dacron Plus Tablet. Please consult your doctor.
Information regarding the use of Dacron Plus Tablet during pregnancy is not available. Please consult your doctor.
Information regarding the use of Dacron Plus Tablet during breastfeeding is not available. Please consult your doctor.
It is not known whether Dacron Plus Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
There is limited information available on the use of Dacron Plus Tablet in patients with kidney disease. Please consult your doctor.
Dacron Plus Tablet should be used with caution in patients with liver disease. Dose adjustment of Dacron Plus Tablet may be needed. Please consult your doctor. However, the use of Dacron Plus Tablet is not recommended in patients with severe liver disease and active liver disease.
If you miss a dose of Dacron Plus Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Purewin Labs Pvt Ltd || ₹14.5/tablet (25% cheaper)